Plasma L -Tryptophan Concentration in Major Depressive Disorder: New Data and Meta-Analysis
The DOI matches its Crossref record.
Abstract
OBJECTIVE: Tryptophan, an essential amino acid, is the precursor to serotonin and is metabolized mainly by the kynurenine pathway. Both serotonin and kynurenine have been implicated in the pathophysiology of major depressive disorder (MDD). However, plasma tryptophan concentration in patients with MDD has not unequivocally been reported to be decreased, which prompted us to perform a meta-analysis on previous studies and our own data. DATA SOURCES: We searched the PubMed database for case-control studies published until August 31, 2013, using the search terms plasma AND tryptophan AND synonyms for MDD. An additional search was performed for the term amino acid instead of tryptophan. We obtained our own data in 66 patients with MDD (DSM-IV) and 82 controls who were recruited from March 2011 to July 2012. The majority of the patients were medicated (N = 53). Total plasma tryptophan concentrations were measured by the liquid chromatography/mass spectrometry method. STUDY SELECTION: We scrutinized 160 studies for eligibility. Original articles that were written in English and documented plasma tryptophan values in patients and controls were selected. DATA EXTRACTION: We included 24 studies from the literature and our own data in the meta-analysis, which involved a total of 744 patients and 793 controls. Data on unmedicated patients (N = 156) and their comparison subjects (N = 203) were also extracted. To see the possible correlation between tryptophan concentrations and depression severity, meta-regression analysis was performed for 10 studies with the Hamilton Depression Rating Scale 17-item version score. RESULTS: In our case-control study, mean (SD) plasma tryptophan level was significantly decreased in the MDD patients versus the controls (53.9 [10.9] vs 57.2 [11.3] μmol/L; P = .03). The meta-analysis after adjusting for publication bias showed a significant decrease in patients with MDD with a modest effect size (Hedges g, -0.45). However, analysis on unmedicated subjects yielded a large effect (Hedges g, -0.84; P = .00015). We found a weak association with depression severity in the meta-regression analysis (P = .049). CONCLUSIONS: This meta-analysis provides convincing evidence for reduced plasma tryptophan levels in patients with MDD, particularly in unmedicated patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, low levels of 5-HT and L-tryptophan, which is a precursor of 5-HT, 54 in blood platelets are also found in depressed people.”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [54]
In the citing paper
“Supporting the present results, a meta-analysis study has shown reduced plasma tryptophan levels in patients with MDD, particularly in unmedicated patients (Ogawa et al., 2014).”
From Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study (2018) · cites this paper as Ogawa et al., 2014
Citations
Cites
Still being checked.
Cited by
Neuroinflammation and depression: A review
Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“53 In addition, low levels of 5-HT and L-tryptophan, which is a precursor of 5-HT, 54 in blood platelets are also found in depressed people.”
BackgroundNeuroinflammation, memory, and depression: new approaches to hippocampal neurogenesis
Wu, A., & Zhang, J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02964-x · Cited by 306
Markers of Oxidative Stress and Neuroprogression in Depression Disorder
Vaváková, M., Ďuračková, Z., & Trebatická, J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/898393 · Cited by 324
Tryptophan in health and disease
(2020) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2019.08.005 · Cited by 294
Metadata
- Authors
- Ogawa, S., Fujii, T., Koga, N., Hori, H., Teraishi, T., Hattori, K., Noda, T., Higuchi, T., Motohashi, N., & Kunugi, H.
- Affiliations
- National Center of Neurology and Psychiatry (JP)
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2014-09-25
- Volume
- 75
- Issue
- 09
- Pages
- e906-e915
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2075618111
- Cited by
- 183
- References
- 0
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 12 · 2023: 19 · 2022: 21 · 2021: 18 · 2020: 26 · 2019: 18 · 2018: 13 · 2017: 9 · 2016: 10 · 2015: 11
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (25861041)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- plasma tryptophan, serotonin, kynurenine pathway, depression severity, unmedicated patients, amino acids, antidepressants, depression biomarkers, Hamilton Depression Rating Scale, publication bias, meta-regression, case-control study, liquid chromatography-mass spectrometry, depression pathophysiology, tryptophan metabolism
- MeSH terms
- Adult, Antidepressive Agents, Major Depressive Disorder, Female, Humans, Male, Psychiatric Status Rating Scales, Tryptophan, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma L -Tryptophan Concentration in Major Depressive Disorder: New Data and Meta-Analysis. https://app.cochat.ai/papers/10.4088/jcp.13r08908
- The paper
- Ogawa, S., Fujii, T., Koga, N., Hori, H., Teraishi, T., Hattori, K., Noda, T., Higuchi, T., Motohashi, N., & Kunugi, H. (2014). Plasma L -Tryptophan Concentration in Major Depressive Disorder: New Data and Meta-Analysis. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.13r08908
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.